Myomo (MYO) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Myomo (MYO) has outperformed Outset Medical (OM) over the past year, gaining 19.5% versus a loss of 74.1%. Over five years, MYO leads with a -89.4% price change compared with -99.4% for OM. Outset Medical is the larger company by market cap ($76.1 million vs $57.0 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MYO | OM |
|---|---|---|
| Share price | $1.44 | $4.05 |
| Market cap | $57.04M | $76.13M |
| 1-day change | +2.13% | -0.98% |
| YTD return | +54.95% | +10.24% |
| 1-year return | +19.49% | -74.13% |
| 5-year return | -89.43% | -99.44% |
| EPS (TTM) | $-0.35 | $-4.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.89 | $15.94 |
| 52-week low | $0.605 | $2.84 |
| Distance from 52-week high | -23.61% | -74.59% |
| Analyst consensus | none | buy |
| Avg. price target upside | +222.22% | +89.38% |
| Average volume | 493.94K | 158.75K |
| Shares outstanding | 39.61M | 18.80M |
| Employees | 194 | 310 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MYO has outperformed OM by 93.6 percentage points over the past year.
About Myomo
MYO stock →Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.
Health Care · Industrial Specialties · 194 employees
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 310 employees
MYO vs OM FAQ
Which is bigger, Myomo or Outset Medical?
Outset Medical (OM) is larger, with a market capitalization of $76.13M compared with $57.04M for Myomo (MYO).
Which stock has performed better over the past year, MYO or OM?
MYO returned +19.49% over the past 12 months, compared with -74.13% for OM (price return, excluding dividends). Past performance does not predict future results.
Are Myomo and Outset Medical in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Myomo and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Outset Medical.